CFDE Data Portal | Search LOC400036

	Label	Description
	LOC400036 Gene (Entity type)	ENSG00000257616 - DEAD-box helicase 23 pseudogene
	GSE113369 p53 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210150 crizotinib cardiac muscle cell 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171988 MBNL knockout Schneider 1 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 4 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Thyroid 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Thyroid 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Prostate 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx

LOC400036

ENSG00000257616 - DEAD-box helicase 23 pseudogene

GSE113369 p53 inhibition 2 v 3 human up

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 5 human up

A Gene Set from LINCS

GSE210150 crizotinib cardiac muscle cell 0 v 1 human up

A Gene Set from LINCS

GSE171988 MBNL knockout Schneider 1 1 v 0 human up

A Gene Set from LINCS

GSE139540 menadione 4 v 1 human up

A Gene Set from LINCS

GTEx Thyroid 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx Thyroid 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Prostate 20-29 vs 40-49 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.